Malignant Peritoneal Mesothelioma: Prognostic Factors and Oncologic Outcome Analysis

BACKGROUND: Most patients with malignant peritoneal mesothelioma (MPM) present with late-stage, unresectable disease that responds poorly to systemic chemotherapy while, at the same time, effective targeted therapies are lacking. We assessed the efficacy of cytoreductive surgery (CRS) and hypertherm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Magge, Deepa, Zenati, Mazen S., Austin, Frances, Mavanur, Arun, Sathaiah, Magesh, Ramalingam, Lekshmi, Jones, Heather, Zureikat, Amer H., Holtzman, Matthew, Ahrendt, Steven, Pingpank, James, Zeh, Herbert J., Bartlett, David L., Choudry, Haroon A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4100549/
https://ncbi.nlm.nih.gov/pubmed/24322529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-013-3358-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados